FR2988857B1 - Procede de determination de la resistance cellulaire aux medicaments. - Google Patents

Procede de determination de la resistance cellulaire aux medicaments.

Info

Publication number
FR2988857B1
FR2988857B1 FR1252922A FR1252922A FR2988857B1 FR 2988857 B1 FR2988857 B1 FR 2988857B1 FR 1252922 A FR1252922 A FR 1252922A FR 1252922 A FR1252922 A FR 1252922A FR 2988857 B1 FR2988857 B1 FR 2988857B1
Authority
FR
France
Prior art keywords
medicaments
cell resistance
determining cell
determining
resistance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1252922A
Other languages
English (en)
Other versions
FR2988857A1 (fr
Inventor
Celine Boutin
Patrick Berthault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Commissariat a lEnergie Atomique CEA
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat a lEnergie Atomique CEA, Commissariat a lEnergie Atomique et aux Energies Alternatives CEA filed Critical Commissariat a lEnergie Atomique CEA
Priority to FR1252922A priority Critical patent/FR2988857B1/fr
Publication of FR2988857A1 publication Critical patent/FR2988857A1/fr
Application granted granted Critical
Publication of FR2988857B1 publication Critical patent/FR2988857B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/46—NMR spectroscopy
    • G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Signal Processing (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FR1252922A 2012-03-30 2012-03-30 Procede de determination de la resistance cellulaire aux medicaments. Expired - Fee Related FR2988857B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1252922A FR2988857B1 (fr) 2012-03-30 2012-03-30 Procede de determination de la resistance cellulaire aux medicaments.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1252922A FR2988857B1 (fr) 2012-03-30 2012-03-30 Procede de determination de la resistance cellulaire aux medicaments.

Publications (2)

Publication Number Publication Date
FR2988857A1 FR2988857A1 (fr) 2013-10-04
FR2988857B1 true FR2988857B1 (fr) 2015-02-20

Family

ID=46514542

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1252922A Expired - Fee Related FR2988857B1 (fr) 2012-03-30 2012-03-30 Procede de determination de la resistance cellulaire aux medicaments.

Country Status (1)

Country Link
FR (1) FR2988857B1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5809801A (en) * 1996-03-29 1998-09-22 The Trustees Of Princeton University Cryogenic accumulator for spin-polarized xenon-129
FI982069A7 (fi) * 1996-03-29 1998-11-10 Lawrence Berkeley Nat Laboratory NMR:n ja MRI:n tehostaminen hyperpolaroitujen jalokaasujen läsnä olles sa
US6125654A (en) * 1998-10-16 2000-10-03 Syracuse University Bulk production and usage of hyperpolarized 129 Xenon
US7805176B2 (en) * 2004-03-10 2010-09-28 University Of Virginia Patent Foundation Exchange-weighted xenon-129 nuclear magnetic resonance system and related method

Also Published As

Publication number Publication date
FR2988857A1 (fr) 2013-10-04

Similar Documents

Publication Publication Date Title
EP3965111B8 (fr) Méthodes d'analyse génomique
IL245935A0 (en) Methods for RNA analysis
IL237486B (en) System and method for measuring lung capacity and stamina
BR112014032116A2 (pt) método.
EP2871470A4 (fr) Biocapteur électrochimique avec précision améliorée
DK3363806T3 (da) Glycokonjugationsfremgangsmåde
DK2621339T3 (da) Avanceret system til kontinuerlig analytmonitorering
EP3591057C0 (fr) Système de coexpression inductible
GB201516569D0 (en) Methods, compositions, and kits for nucleic acid analysis
GB201218555D0 (en) Immunoassay using electrochemical detection
ITRM20120383A1 (it) Metodo e kit per la rivelazione di anticorpi.
FR2964459B1 (fr) Procede de cartographie de la concentration en oxygene
BR112014010125A2 (pt) sistema eletroquímico
EP2832465A4 (fr) Procédé d'analyse de formage sous pression
ZA201404463B (en) Detecting analytes
FR2993074B1 (fr) Procede de tatouage de livres numeriques
BR112014029259A2 (pt) método, aparelho e produto eletrolítico
SG11201406865PA (en) Assays, methods and apparatus for assessing rna disruption
PL2972368T3 (pl) Biomarkery limfocytów do określania odpowiedzi klinicznej na terapię komórkową
FR2988479B1 (fr) Procede de determination de la susceptibilite aux infections nosocomiales
BR112014016917A8 (pt) processamento de células
EP2795304A4 (fr) Détecteurs électrochimiques
FR2998290B1 (fr) Procede de potabilisation
DK2739729T3 (da) Celle, der fermenterer pentosesukker
DK2681530T3 (da) Gennemstrømmelig målecelle

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

ST Notification of lapse

Effective date: 20221105